Becton, Dickinson and Company
As of Oct 23, 2026 close
- Market cap
- $54.73B
- P/E (TTM)
- 58.16
- Forward P/E
- 101.24
- Dividend yield
- 2.10%
- 52-week range
- $140.11$213.08
- Volume (live)
- -
- Avg. volume (3M)
- 1.67M
Becton, Dickinson and Company (BDX) Stock Price & Financial Analysis
Becton, Dickinson and Company Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $197.15 - $200.42 |
|---|---|
| 52-Week High | $213.08 |
| 52-Week Low | $140.11 |
| Open | $199.18 |
| Volume (last close) | 1.30M |
| Average Volume (3M) | 1.67M |
| Revenue (TTM) | 20.84B |
|---|---|
| Net Income (TTM) | 941.00M |
| Free Cash Flow (TTM) | 2.60B |
| EPS (TTM) | $3.33 |
| Profit Margin | 4.52% |
| Operating Margin | 10.58% |
| Return on Equity (ROE) | 3.85% |
| Debt to Equity | 0.69 |
| Annual Dividend | $4.20 |
|---|---|
| Dividend Yield | 2.10% |
| Payout Ratio | 125.95% |
| Last Dividend Ex-Date | Sep 9, 2026 |
| Market Cap | 54.73B |
|---|---|
| Shares Outstanding | 275.16M |
| P/E Ratio (TTM) | 58.16 |
| Forward P/E | 101.24 |
| Price to Sales (P/S) | 2.63 |
| Price to Book (P/B) | 2.24 |
| EV/EBITDA | 14.55 |
| 50-Day MA | $184.44 |
|---|---|
| 200-Day MA | $169.96 |
| 1-Year Change | +7.45% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Becton, Dickinson and Company at a Glance
As of the Oct 23, 2026 close, Becton, Dickinson and Company (BDX) has a market capitalization of $54.73B. The stock trades at 58.2× trailing earnings, 101.2× forward earnings and 2.6× sales. Over the trailing twelve months it earned $941.00M on revenue of $20.84B (a 4.5% profit margin) and generated $2.60B of free cash flow. Revenue fell 2.3% year over year.
As of its latest reported balance sheet, it holds $708.00M in cash and securities against $16.81B of debt, a net debt position of $16.10B.
Becton, Dickinson and Company pays a quarterly dividend totaling $4.20 per share a year, a 2.10% yield at the Oct 23, 2026 close, with a 126% payout ratio and 42 consecutive years of dividend increases.
The share price is up 7.4% over the past year. At $198.91 (the Oct 23, 2026 close) it sits within its 52-week range of $140.11 to $213.08, above its 200-day moving average of $169.96.
Based on 13 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $191.80, 3.6% below the Oct 23, 2026 close.
Frequently Asked Questions About Becton, Dickinson and Company
What is the current stock price for BDX?
As of the Oct 23, 2026 close, BDX stock trades at $198.91. The 52-week range is $140.11–$213.08, with a day range of $197.15–$200.42.
What is the P/E ratio for BDX?
As of the Oct 23, 2026 close, Becton, Dickinson and Company's trailing twelve-month (TTM) P/E ratio is 58.2, meaning investors pay $58.2 for every $1 of annual earnings. The forward P/E is 101.2, reflecting analyst expectations for future earnings. Becton, Dickinson and Company operates in the Healthcare sector.
Does BDX pay dividends?
Yes, Becton, Dickinson and Company pays a 2.10% annual dividend yield as of the Oct 23, 2026 close ($4.20 per share a year). The trailing twelve-month payout ratio is 126.0%. The most recent ex-dividend date was September 9, 2026.
What do analysts recommend for BDX?
Based on ratings from 13 professional analysts over the last 90 days, the consensus for BDX is Buy. The average 12-month price target is $191.80, a 3.6% downside from the Oct 23, 2026 close of $198.91.
What is the market cap of BDX?
As of the Oct 23, 2026 close, Becton, Dickinson and Company's market capitalization is $54.73B, classifying it as a large-cap company. Becton, Dickinson and Company operates in the Healthcare sector within the Medical Instruments & Supplies industry.